STEP-BD
Systematic Treatment Enhancement Program for Bipolar Disorder
Overview of STEP-BD study
. 4360 adult outpatients (1998-2005)
. Antipsychotics, Anti-epiletpitcs, and anti-depressants were used
. Types of psychotherapy used: family focused, interpersonal rhythm (sleep) therapy, CBT
. versus the control group which was “brief, collaborative professional contact.”
STEP-BD early take homes
. After two years: 58.4% achieved recovery; 48.% had a recurrence (72% were depressive episode)
. Recurrence occurred in those who had residual symptoms (not full remission).
. There was no benefit found in adding an antidepressant to a mood stabilizer.
. There were no differences found between lamotrigine, risperidone, or inositol.
STEP-BD take-homes for women
. Valproic acid (10.5% of the women were on Valproic acid and 1.4% were on another agent).
.increased the risk of polycystic ovary syndrome (PCOS).
. .increased menstrual irregulairiites
. acne
. a male pattern hair loss process
. elevated testosterone
. excessive body hair
STEP-BD Take homes (five); Peters and colleagues (2011)- reanalysis of the data set
STEP-BD Take-homes (El-Mallakh, et al., 2015). They did a reanalysis of the Step data set
STEP-BD Take-Homes (Tada & colleagues, 2015)- reanalysis of the STEP data set.
. High dose antidepressants may be effective with patients with no mood destabilization, mania, or adverse events early in treatment.
STEP-BD Take Homes (Mizushima et al., 2017)- reanalysis of the STEP data set.